Automated insulin delivery (AID) system

DEVICE3 trials

Sponsors

University of Virginia, McGill University Health Centre/Research Institute of the McGill University Health Centre, University of California, San Francisco

Conditions

Diabetes Mellitus, Type 1Pre-Gestational DiabetesPregnancyType 1 Diabetes (T1D)Type 1 Diabetes Mellitustype1diabetes

Phase 2

A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes

RecruitingNCT06046417

McGill University Health Centre/Research Institute of the McGill University Health CentreDiabetes Mellitus, Type 1, type1diabetes

Start: 2023-11-30End: 2025-06-30Target: 30Updated: 2024-04-18

Unknown Phase

Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery

CompletedNCT04784637

University of VirginiaType 1 Diabetes Mellitus

Start: 2021-07-23End: 2021-12-24Updated: 2024-11-07

Automated Insulin for Management of Intrapartum Glycemia

RecruitingNCT06883344

University of California, San FranciscoPre-Gestational Diabetes, Pregnancy, Type 1 Diabetes (T1D)

Start: 2025-12-05End: 2026-12-31Target: 150Updated: 2026-02-05